Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia
Author: Bottomley, S.
May, B.
Cox, T.
Cotter, P.
Bishop, D.
Citation: Journal of Bioenergetics and Biomembranes, 1995; 27(2):161-168
Publisher: Plenum Publishing Corporation
Issue Date: 1995
ISSN: 0145-479X
Statement of
Bottomley, Sylvia; May, Brian; Cox, Timothy; Cotter, Philip; Bishop, David
Abstract: The erythroid-specific isozyme of 5-aminolevulinate synthase (ALAS2), the first and ratelimiting enzyme of heme biosynthesis, is expressed concomitantly with the differentiation and maturation of the erythroid cell in order to accommodate generation of the large amounts of heme required for hemoglobin production. During the past few years the ALAS2 gene and its transcript have been characterized and the amino acid sequence of the enzyme deduced. The human genetic disorder X-linked sideroblastic anemia, previously postulated to be caused by defects of ALAS, has now been analyzed at the molecular and tissue-specific level. A heterogeneous group of point mutations in the catalytic domain of the ALAS2 enzyme has been found to cause the disorder. Impaired activity of recombinant mutant ALAS2 enzymes has also been demonstrated. Characterization of molecular defects in individuals with X-linked sideroblastic anemia has provided improved diagnosis for at-risk family members.
DOI: 10.1007/BF02110031
Appears in Collections:Aurora harvest 2
Biochemistry publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.